This year marks the eighth annual Tardive Dyskinesia Awareness Week. Since the first TD Awareness Week took place in 2018, all 50 states and Washington, D.C., have recognized this important week, and TDAW continues to grow. Neurocrine Biosciences is committed to bringing awareness to TD every day, but especially during TDAW, to demonstrate support to the at least 800,000 people living with tardive dyskinesia, including approximately 60% who have not yet been diagnosed.